Pharsight

Drugs that contain Gabapentin

1. Gralise patents expiration

GRALISE's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6340475 ALMATICA Extending the duration of drug release within the stomach during the fed mode
Sep, 2016

(7 years ago)

US6635280 ALMATICA Extending the duration of drug release within the stomach during the fed mode
Sep, 2016

(7 years ago)

US6488962 ALMATICA Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
Jun, 2020

(3 years ago)

US6723340 ALMATICA Optimal polymer mixtures for gastric retentive tablets
Oct, 2021

(2 years ago)

US7731989 ALMATICA Gastric retained gabapentin dosage form
Oct, 2022

(1 year, 6 months ago)

US8192756 ALMATICA Gastric retained gabapentin dosage form
Oct, 2022

(1 year, 6 months ago)

US8252332 ALMATICA Gastric retained gabapentin dosage form
Oct, 2022

(1 year, 6 months ago)

US8333992 ALMATICA Gastric retained gabapentin dosage form
Oct, 2022

(1 year, 6 months ago)

US7438927 ALMATICA Methods of treatment using a gastric retained gabapentin dosage
Feb, 2024

(2 months ago)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE) Jan 28, 2018
Orphan Drug Exclusivity(ODE-6) Jan 28, 2018
New Product(NP) Jan 28, 2014

Market Authorisation Date: 28 January, 2011

Treatment: Treatment with gabapentin, including treatment of neuropathic pain, including neuropathic pain associated with postherpetic neuralgia

Dosage: TABLET;ORAL

How can I launch a generic of GRALISE before it's drug patent expiration?
More Information on Dosage

GRALISE family patents

Family Patents

2. Neurontin patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6054482 VIATRIS Lactam-free amino acids
Apr, 2017

(7 years ago)

US6054482

(Pediatric)

VIATRIS Lactam-free amino acids
Oct, 2017

(6 years ago)

US7256216 VIATRIS Liquid pharmaceutical compositions
May, 2022

(1 year, 11 months ago)

US7256216

(Pediatric)

VIATRIS Liquid pharmaceutical compositions
Nov, 2022

(1 year, 5 months ago)

Market Authorisation Date: 02 March, 2000

Treatment: NA

Dosage: SOLUTION;ORAL; CAPSULE;ORAL; TABLET;ORAL

How can I launch a generic of NEURONTIN before it's drug patent expiration?
More Information on Dosage

NEURONTIN family patents

Family Patents